Breast - Non Cosmetic Flashcards
Lifetime risk of breast CA
12%
Difference between multifocal DCIS and multicentric DCIS
Multifocal DCIS present in more than 2 areas within SAME quadrant
Multicentric DCIS present in discontinuous foci involving more than one breast quadrant
Median age of diagnosis of breast cancer
62
Risk Factors for Breast CA
Age at Menarche: reduction of risk of 5-10% for each year delay in age at menarche
Gene mutations: BRCA, p53, PTEN, cdh1 …
Parity: Each birth reduces the relative risk of breast cancer by 7%
Age at First Full-Term Pregnancy: Increased risk with first full term pregnancy > 35, difficult to quantify
Breastfeeding: Relative risk of breast cancer decreased by 4.3% for every 12 months of breastfeeding
Age at Menopause: For each year delay in age of menopause, the risk for breast cancer increases by 3%
Exogenous Hormones: Use increases the risk by 2.3% for each year of use. This effect disappears 5 years after discontinuing, regardless of duration of use.
Obesity: 1.25 to 2-fold excess risk among postmenopausal obese women
Alcohol: Increased relative risk of 32% for 4-6 drinks/week
Physical Activity: Risk reductions of 10-50%
Ionizing Radiation: Depends on age at exposure. The elevated risk persists.
Mammographic Density: Women with dense breast tissue have a 2 to 6-fold increased risk
If left untouchced what % of DCIS will progress to Cancer
30%
Candidates for breast conserving therapy in DCIS
- Unicentric (Localized) Disease
- Tumor to breast esize ratio allows for acceptable cosmetic results
- Possible to attain margins greater or equal to 2mm.
- No evidence of diffuse microcalcification or multicentric disease
- No contraindication to radiation therapy
Patient on Tamoxifen for ER+ tumor following their oncoplastic reduction. What side effects do you council them on.
vasomotor symptoms, DVT/PE, stroke, cataract formation, benign ovarian cysts, risk for endometrial cancer increased 2-7x
Name the hereditary breast cancers secondary to genetic mutations
BRCA1, BRCA2, p53 (Li Fraumeni Syndrome), PTEN (Cowdens Disease), STK11 (Peutz-Jeghers), Lynch Syndrome
BRCA1 mutation lifetime risk of breast CA?
BRCA2 mutation lifetime risk of breast CA?
BRCA1= 55%-65% BRCA2= 45%-55%
What is the most suspicious mammographic findings for malignancy
- spiculated massess with associated architectural distortional
- clustered microcalcifications in a linear or branching array
- microcalcifications associated with a mass.
In which patients is ultrasound a better test than mammography for diagnosing breast cancer
young females with dense breasts
Molecular subtypes of breast CA
Luminal A- ER+, PR+, HER2-, Ki67 low
Luminal B- ER+, PR+ HER2+ (or HER2- with Ki67 high)
Basal Like - ER-, PR-, HER2-
HER2 enriched - ER-, PR-, HER2+
Define locally advanced breast cancer
Generally = Stage III
- Any tumour greater than 5cm (T4)
- Any size tumour with multiple nodes involved (N2 or greater or greater than 4-9 nodes.)
- Inflammatory Breast cancer
Inflammatory breast cancer is denoted within AJCC staging system at what T class
T4d = an aggressive form of locally advanced breast cancer
characteristic pathologic finding making diagnosis of inflammatory breast cancer
dermal lymphatic invasion by carcinoma on skin punch biopsy
Can you do immediate breast reconstruction in inflammatory breast cancer
no. Immidiate reconstruction is contraindicated in the setting of inflammatory breast cancer. breast recon should be delayed as nearly all patients will require chest wall and regional nodal radiation, to include axillary , periclavicular and IM nodes.
List conventional indications for nipple sparing mastectomy
- women with early stage tumors located more than 2 cm from the nipple with a clinically negative axilla
- very large or ptotic breasts are relative contraindications
What is the relative risk reduction for breast CA with a prophylactic mastectomy in high risk patients
90-95%
Studies have shown that X % of patients with early stage clinically node negative breast cancer will have a positive sentinel node
24%
ALND consists of removal of what
Level 1 and Level 2 axillary nodal tissue. Level 3 removal increases risk of lymphedema substantially so is only removed when clinically positive.
Describe the concept of delayed-immidiate breast recosntruction
In cases where the need for PMRT is unknown the patient undergoes skin sparing mastectimy with insertion of a saline filled tissue expander. This serves as a scaffold to preserve the 3D contour of the breast skin envelope. Following pathologic evaluation, if the patient needs PMRT, the expander is deflated to allow radiation therapy, followed by delayed recon, usually autologous. If no PMRT required, they are serially expanded and then can undergo autologous or alloplastic reconstruction
Results of the ATAC trial
trial assessing the efficacy and side effect profiles of anastrazole and tamoxifen in post menopausal women. For postmenopausal patients with early stage cancer anastrazole had higher disease free survival and longer time to recurrence . The incidence of edometrial cancer, VTE and vaginal symptoms was also decreased with anastrazole. As a result of the ATAC trial, anastrazole is now the preferred hormone therapy over tamoxifen for postmenopausal patients with receptor positive breast cancer
How long should you hold Tamoxifen before performing a DIEP
2 weeks. It increases the risk of VTE
Describe the Huger Zones
The 3 vascular zones of the abdominal wall.
Zone 1=costal margins, lateral edge of recutus down to pubis. Supplied by the superior and inferior epigastric system.
Zone 2= Anything inferior to line between iliac crests. SCIA, DCIA and External Puodendal arteries.
Zone 3=Lateral to rectus above the line between iliac crests. Intercostal, subcostal and lumbar
Describe blood supply to umbilicus (4)
- Subdermal Plexus
- DIEA
- Ligamentum Teres Hepatis
- Medial Umbilical Ligament